An unloved stock and non-viral substitution competitor to Oxford BioMedica (LON:OXB) in the ex-vivo CGT market
Share this post
MaxCyte (NASDAQ:MXCT, LON:MXCT): unsexy genes
Share this post
An unloved stock and non-viral substitution competitor to Oxford BioMedica (LON:OXB) in the ex-vivo CGT market